NOD2 plays a role in the immune response to intracellular bacterial lipopolysaccharides by triggering activation of MAP kinases and NFκB signaling and mutations in NOD2 have been correlated with increased risk of Crohn’s disease [20]. This evidence concerns the gene NFKB1 and Crohn disease.